Dysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · see citing works

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

Metabolite profiles and the risk of developing diabetes

Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143 · see citing works

Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics

Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A., & Schwudke, D. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d700041-jlr200 · Cited by 2,615 · see citing works

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Sreekumar, A., Poisson, L., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,238 · see citing works

Update of the LIPID MAPS comprehensive classification system for lipids

Fahy, E., Subramaniam, S., Murphy, R. C., Nishijima, M., Raetz, C. R. H., Shimizu, T., Spener, F., Gerrit van, M. E. E. R., Wakelam, M. J. O., & Dennis, E. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800095-jlr200 · Cited by 1,766 · see citing works

Ion Suppression in Mass Spectrometry

Annesley, T. M. (2003) · Clinical Chemistry · doi:10.1373/49.7.1041 · Cited by 1,598 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples

Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,111 · see citing works

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 1,107 · see citing works

Plasma phospholipids identify antecedent memory impairment in older adults

Mapstone, M. E., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,031 · see citing works

Lipidomics: coming to grips with lipid diversity

Shevchenko, A., & Simons, K. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2934 · Cited by 828 · see citing works

Apolipoprotein E ε4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease

Kivipelto, M., Helkala, E., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A. M., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645 · see citing works

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 562 · see citing works

Identification of type 2 diabetes subgroups through topological analysis of patient similarity

Li, L., Cheng, W., Glicksberg, B. S., Gottesman, O., Tamler, R., Chen, R., Böttinger, E. P., & Dudley, J. T. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9364 · Cited by 548 · see citing works

Deregulation of sphingolipid metabolism in Alzheimer’s disease

He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516 · see citing works

Differences between Human Plasma and Serum Metabolite Profiles

Yu, Z., Kastenmüller, G., He, Y., Belcredi, P., Möller, G., Prehn, C. P., Mendes, J., Wahl, S., Roemisch‐Margl, W., Ceglarek, U., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021230 · Cited by 496 · see citing works

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438 · see citing works

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics

Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429 · see citing works

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

Füzéry, A. K., Levin, J. D., Chan, M. M., & Chan, D. W. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-13 · Cited by 428 · see citing works

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Dieterle, F., Sistare, F. D., Goodsaid, F. M., Papaluca, M., Ozer, J. S., Webb, C. P., Baer, W., Senagore, A. J., Schipper, M. J., Vonderscher, J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1625 · Cited by 410 · see citing works

Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

Drucker, E., & Krapfenbauer, K. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-7 · Cited by 352 · see citing works

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease

Whiley, L., Sen, A., Heaton, J. C., Proitsi, P., García‐Gómez, D., Leung, R., Smith, N. W., Thambisetty, M., Kłoszewska, I., Mecocci, P., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.001 · Cited by 342 · see citing works

Sphingolipids and Cancer: Ceramide and Sphingosine-1-Phosphate in the Regulation of Cell Death and Drug Resistance

Ponnusamy, S., Meyers‐Needham, M., Senkal, C. E., Saddoughi, S. A., Sentelle, D., Selvam, S. P., Salas, A., & Öğretmen, B. (2010) · Future Oncology · doi:10.2217/fon.10.116 · Cited by 313 · see citing works

Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial

Scheltens, P., Twisk, J. W. R., Blesa, R., Scarpini, E. A., Arnim, C. A. F. V., Bongers, A., Harrison, J., Willemsen‐Swinkels, S. H. N., Stam, C. J., de Waal, H., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121189 · Cited by 306 · see citing works

Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research

O’Bryant, S. E., Gupta, V. B., Henriksen, K., Edwards, M., Jeromin, A., Lista, S., Bazenet, C. E., Soares, H. D., Lovestone, S., Hampel, H. J., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.08.099 · Cited by 290 · see citing works

An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids

Surma, M. A., Herzog, R., Vasilj, A., Klose, C. D., Christinat, N., Morin‐Rivron, D., Simons, K., Masoodi, M., & Sampaio, J. L. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201500145 · Cited by 285 · see citing works

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

Xiong, H., Callaghan, D., Jones, A., Walker, D. G., Lue, L., Beach, T. G., Sue, L. I., Woulfe, J., Xu, H., Stanimirovic, D. B., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.10.005 · Cited by 283 · see citing works

SYMPOSIUM REVIEW: Lipid microdomains and the regulation of ion channel function

Dart, C. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.191585 · Cited by 268 · see citing works

UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: Effect of experimental artefacts and anticoagulant

Barri, T., & Dragsted, L. O. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2013.01.015 · Cited by 268 · see citing works

Lipidomics: Analysis of the Lipid Composition of Cells and Subcellular Organelles by Electrospray Ionization Mass Spectrometry

Brügger, B. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035324 · Cited by 265 · see citing works

A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL

Reis, A., Rudnitskaya, A. M., Blackburn, G. J., Fauzi, N. M., Pitt, A. R., & Spickett, C. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034330 · Cited by 242 · see citing works

Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples

Breier, M., Wahl, S., Prehn, C. P., Fugmann, M., Ferrari, U., Weise, M., Banning, F., Seißler, J., Grallert, H., Adamski, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089728 · Cited by 240 · see citing works

Serum ceramides increase the risk of Alzheimer disease

Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Xia, J., Fried, L. P., Yaşar, S., Albert, M., Varma, V. R., Harris, G., Schneider, E. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318264e380 · Cited by 223 · see citing works

An Efficient Single Phase Method for the Extraction of Plasma Lipids

Alshehry, Z. H., Barlow, C. K., Weir, J. M., Zhou, Y., McConville, M. J., & Meikle, P. J. (2015) · Metabolites · doi:10.3390/metabo5020389 · Cited by 219 · see citing works

Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease

Claxton, A., Baker, L. D., Wilkinson, C. W., Trittschuh, E. H., Chapman, D., Watson, G. S., Cholerton, B., Plymate, S. R., Arbuckle, M., & Craft, S. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-122308 · Cited by 215 · see citing works

Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals

Song, F., Poljak, A., Crawford, J., Kochan, N. A., Wen, W., Cameron, B., Lux, O., Brodaty, H., Mather, K., Smythe, G. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034078 · Cited by 214 · see citing works

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers

Košiček, M., & Hecimovic, S. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011310 · Cited by 213 · see citing works

Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Hong, S., Ostaszewski, B. L., Yang, T., O’Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., & Selkoe, D. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.027 · Cited by 213 · see citing works

Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers

Dhingra, R., & Vasan, R. S. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.07.005 · Cited by 212 · see citing works

Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death

Mullen, T. D., & Obeid, L. M. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800228661 · Cited by 204 · see citing works

Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis

Proitsi, P., Kim, M. G., Whiley, L., Simmons, A., Sattlecker, M., Velayudhan, L., Lupton, M. K., Soininen, H., Kłoszewska, I., Mecocci, P., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.08.003 · Cited by 203 · see citing works

APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms

Conejero-Goldberg, C., Gomar, J. J., Bobes-Bascaran, T., Hyde, T. M., Kleinman, J. E., Herman, M. M., Chen, S., Davies, P., & Goldberg, T. E. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.194 · Cited by 199 · see citing works

Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis

Satoi, H., Tomimoto, H., Ohtani, R., Kitano, T., Kondo, T., Watanabe, M., Oka, N., Akiguchi, I., Furuya, S., Hirabayashi, Y., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.056 · Cited by 195 · see citing works

Local cholesterol increase triggers amyloid precursor protein‐Bacel clustering in lipid rafts and rapid endocytosis

Marquer, C., Devauges, V., Cossec, J., Liot, G., Lécart, S., Saudou, F., Duyckaerts, C. J., Lévêque‐Fort, S., & Potier, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-168633 · Cited by 188 · see citing works

Plasma and Serum Lipidomics of Healthy White Adults Shows Characteristic Profiles by Subjects’ Gender and Age

Ishikawa, M., Maekawa, K., Saito, K., Senoo, Y., Urata, M., Murayama, M., Tajima, Y., Kumagai, Y., & Saito, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091806 · Cited by 187 · see citing works

Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease

Meikle, P. J., Wong, G., Barlow, C. K., & Kingwell, B. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.001 · Cited by 185 · see citing works

Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms

Köfeler, H. C., Fauland, A., Rechberger, G. N., & Trötzmüller, M. (2012) · Metabolites · doi:10.3390/metabo2010019 · Cited by 181 · see citing works

Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer?s disease

Mulder, C., Wahlund, L., Teerlink, T., Blomberg, M. I., Veerhuis, R., van Kamp, G. J., Scheltens, P., & Scheffer, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0007-9 · Cited by 174 · see citing works

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease

Song, F., Poljak, A., Smythe, G. A., & Sachdev, P. S. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.003 · Cited by 173 · see citing works

Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Schech, S., Carrick, R., Carlson, M. C., Mori, S., Miller, M. I., Ceritoglu, C., Brown, T., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.014 · Cited by 170 · see citing works

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients

Walter, A., Korth, U., Hilgert, M., Hartmann, J., Weichel, O., Hilgert, M., Fassbender, K. C., Schmitt, A., & Klein, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.016 · Cited by 165 · see citing works

Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions

Fabelo, N., Martín, M. V., Marín, R., Moreno, D., Ferrer, I., & Díaz, M. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.005 · Cited by 164 · see citing works

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

Casanova, R., Varma, S., Simpson, B. N., Kim, M. G., An, Y., Saldana, S. J., Riveros, C., Moscato, P., Griswold, M. E., Sonntag, D., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.12.008 · Cited by 162 · see citing works

The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population

Alshaarawy, O., Elbaz, H. A., & Andrew, M. E. (2016) · Environment International · doi:10.1016/j.envint.2016.02.006 · Cited by 162 · see citing works

Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis

Couttas, T. A., Kain, N., Daniels, B., Lim, X. Y., Shepherd, C., Kril, J., Pickford, R., Li, H., Garner, B., & Don, A. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-9 · Cited by 161 · see citing works

Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease

Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Darby, E. J., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110405 · Cited by 158 · see citing works

ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.

Bandaru, V. R., Troncoso, J., Wheeler, D., Pletnikova, O., Wang, J., Conant, K., & Haughey, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.024 · Cited by 157 · see citing works

Serum total cholesterol, statins and cognition in non-demented elderly

Solomon, A., Kåreholt, I., Ngandu, T., Wolozin, B., MacDonald, S. W. S., Winblad, B., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.09.012 · Cited by 149 · see citing works

Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality

Zuo, H., Ueland, P., Ulvik, A., Eussen, S., Vollset, S., Nygård, O., Midttun, Ø., Theofylaktopoulou, D., Meyer, K., & Tell, G. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv242 · Cited by 149 · see citing works

Lipid changes in the aged brain: Effect on synaptic function and neuronal survival

Ledesma, M. D., Martín, M. G., & Dotti, C. G. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.004 · Cited by 148 · see citing works

Involvement of Sphingosine-1-Phosphate in Glutamate Secretion in Hippocampal Neurons

Kajimoto, T., Okada, T., Yu, H., Goparaju, S. K., Jahangeer, S. M., & Nakamura, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01465-06 · Cited by 146 · see citing works

Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease

González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.01.014 · Cited by 144 · see citing works

Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients

Lazar, A. N., Bich, C., Panchal, M., Desbenoît, N., Petit, V. W., Touboul, D., Dauphinot, L., Marquer, C., Laprévôte, O., Brunelle, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1041-1 · Cited by 141 · see citing works

The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia

Muhlestein, J. B., May, H. T., Jensen, J. R., Horne, B. D., Lanman, R. B., Lavasani, F., Wolfert, R. L., Pearson, R. R., Yannicelli, H. D., & Anderson, J. L. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.009 · Cited by 140 · see citing works

Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development

Karsdal, M. A., Henriksen, K., Leeming, D. J., Mitchell, P. G., Duffin, K. L., Barascuk, N., Klickstein, L. B., Aggarwal, P., Nemirovskiy, O. V., Byrjalsen, I., et al. (2009) · Biomarkers · doi:10.1080/13547500902777608 · Cited by 135 · see citing works

The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study

de Waal, H., Stam, C. J., Lansbergen, M. M., Wieggers, R. L., Kamphuis, P. J. G. H., Scheltens, P., Maestú, F., & van Straaten, E. C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086558 · Cited by 119 · see citing works

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease

Shah, R. C., Kamphuis, P. J., Leurgans, S., Swinkels, S. H., Sadowsky, C. H., Bongers, A., Rappaport, S. A., Quinn, J. F., Wieggers, R. L., Scheltens, P., et al. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt224 · Cited by 112 · see citing works

Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia

Han, X., Fagan, A. M., Cheng, H., Morris, J. C., Xiong, C., & Holtzman, D. M. (2003) · Annals of Neurology · doi:10.1002/ana.10618 · Cited by 111 · see citing works

The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

Klavins, K., Koal, T., Dallmann, G., Marksteiner, J., Kemmler, G., & Humpel, C. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.003 · Cited by 110 · see citing works

Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry

Panchal, M., Loeper, J., Cossec, J., Perruchini, C., Lazar, A., Pompon, D., & Duyckaerts, C. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001859 · Cited by 106 · see citing works

Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk

Greving, J. P., Buskens, E., Koffijberg, H., & Algra, A. (2008) · Circulation · doi:10.1161/circulationaha.107.735340 · Cited by 103 · see citing works

Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease

Košiček, M., Zetterberg, H., Andreasen, N., Peter‐Katalinić, J., & Hecimovic, S. K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.019 · Cited by 102 · see citing works

Biomarker Discovery and Translation in Metabolomics

Gowda, G. N., & Raftery, D. (2013) · Current Metabolomics · doi:10.2174/2213235x113019990005 · Cited by 102 · see citing works

Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume

Choi, S., Chae, A., Miller, E. R., Messig, M., Ntanios, F. Y., DeMaria, A. N., Nissen, S. E., Witztum, J. L., & Tsimikas, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.066 · Cited by 98 · see citing works

GM1 ganglioside and Alzheimer’s disease

Yanagisawa, K. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9579-5 · Cited by 93 · see citing works

Optimizing the lipidomics workflow for clinical studies—practical considerations

Hyötyläinen, T., & Orešič, M. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8633-2 · Cited by 92 · see citing works

Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease

Bennett, S. A. L., Valenzuela, N., Xu, H., Franko, B., Fai, S., & Figeys, D. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00168 · Cited by 86 · see citing works

Demographic and clinical variables affecting mid‐ to late‐life trajectories of plasma ceramide and dihydroceramide species

Mielke, M. M., Bandaru, V. V. R., Han, D., An, Y., Resnick, S. M., Ferrucci, L., & Haughey, N. J. (2015) · Aging Cell · doi:10.1111/acel.12369 · Cited by 85 · see citing works

Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons

Schneider, A., Schulz‐Schaeffer, W., Hartmann, T., Schulz, J. B., & Simons, M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.015 · Cited by 84 · see citing works

Comparison of blood plasma sample preparation methods for combined LC–MS lipidomics and metabolomics

Patterson, R. E., Ducrocq, A. J., McDougall, D. J., Garrett, T. J., & Yost, R. A. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.08.018 · Cited by 80 · see citing works

Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging

Mielke, M. M., Bandaru, V. V. R., Han, D., An, Y., Resnick, S. M., Ferrucci, L., & Haughey, N. J. (2014) · Aging Cell · doi:10.1111/acel.12275 · Cited by 79 · see citing works

Healthy Lifestyle Characteristics and Their Joint Association With Cardiovascular Disease Biomarkers in US Adults

Loprinzi, P. D., Branscum, A. J., Hanks, J. E., & Smit, E. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.01.009 · Cited by 76 · see citing works

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC‐NCS)

Li, D., Misialek, J. R., Boerwinkle, E., Gottesman, R. F., Sharrett, A. R., Mosley, T. H., Coresh, J., Wruck, L. M., Knopman, D. S., & Alonso, Á. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.02.008 · Cited by 71 · see citing works

Liquid Chromatography–Tandem Mass Spectrometry-Based Plasma Metabonomics Delineate the Effect of Metabolites’ Stability on Reliability of Potential Biomarkers

Yang, W. Q., Chen, Y., Xi, C., Zhang, R., Song, Y., Zhan, Q., Bi, X., & Abliz, Z. (2013) · Analytical Chemistry · doi:10.1021/ac303576b · Cited by 67 · see citing works

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Zetterberg, H., Blennow, K., Andréasson, U., Johnson, S. C., Gleason, C. E., Blazel, H. M., Puglielli, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.019 · Cited by 66 · see citing works

Blood metabolite markers of cognitive performance and brain function in aging

Simpson, B. N., Kim, M. G., Chuang, Y., Beason‐Held, L. L., Kitner‐Triolo, M. H., Kraut, M. A., Lirette, S. T., Windham, B. G., Griswold, M. E., Legido‐Quigley, C., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15611678 · Cited by 65 · see citing works

Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes

Lin, J., Hu, F. B., Mantzoros, C. S., & Curhan, G. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1597-z · Cited by 61 · see citing works

A highly efficient, high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood

Song, J., Liu, X., Wu, J., Meehan, M. J., Blevitt, J. M., Dorrestein, P. C., & Milla, M. E. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.10.022 · Cited by 61 · see citing works

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)

Wood, P. L., Locke, V. A., Herling, P., Passaro, A., Vigna, G. B., Volpato, S., Valacchi, G., Cervellati, C., & Zuliani, G. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.11.004 · Cited by 60 · see citing works

GM1 Ganglioside and the Seeding of Amyloid in Alzheimer’s Disease: Endogenous Seed for Alzheimer Amyloid

Yanagisawa, K. (2005) · The Neuroscientist · doi:10.1177/1073858405275177 · Cited by 55 · see citing works

Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study

Chatterjee, P., Lim, W. L. F., Shui, G., Gupta, V. B., JAMES, I. R., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150948 · Cited by 52 · see citing works

Discovering and validating between-subject variations in plasma lipids in healthy subjects

Begum, H., Li, B., Shui, G., Cazenave‐Gassiot, A., Soong, R. C. T., Ong, R. T., Little, P., Teo, Y., & Wenk, M. R. (2016) · Scientific Reports · doi:10.1038/srep19139 · Cited by 50 · see citing works

Neuronal β‐amyloid generation is independent of lipid raft association of β‐secretase BACE1: analysis with a palmitoylation‐deficient mutant

Motoki, K., Kume, H., Oda, A., Tamaoka, A., Hosaka, A., Kametani, F., & Araki, W. (2012) · Brain and Behavior · doi:10.1002/brb3.52 · Cited by 45 · see citing works

Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development

Schalken, J. A. (2010) · European Urology · doi:10.1016/j.eururo.2010.02.025 · Cited by 45 · see citing works

Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population

Harmon, M. E., Campen, M. J., Miller, C. P., Shuey, C., Cajero, M., Lucas, S., Pacheco, B., Erdei, E., Ramone, S., Nez, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0143102 · Cited by 45 · see citing works

Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles

Miyamoto, K., Takeuchi, D., Inai, K., Shinohara, T., & Nakanishi, T. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0807-0 · Cited by 44 · see citing works

The Pathogenic Role of Ganglioside Metabolism in Alzheimer’s Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis

Ariga, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9641-0 · Cited by 43 · see citing works

Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: Method development and application in hepatocellular carcinoma

Li, J., Hu, C., Zhao, X., Dai, W., Chen, S., Lu, X., & Xu, G. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.10.064 · Cited by 41 · see citing works

The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease

Hanson, A. J., Craft, S., & Banks, W. A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141020164222 · Cited by 41 · see citing works

Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies

Welsh, P. I., Hart, C., Papacosta, O., Preiss, D., McConnachie, A., Murray, H. M., Ramsay, S. E., Upton, M. N., Watt, G. C. M., Whincup, P. H., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06501 · Cited by 40 · see citing works

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model

Cho, S. M., Kim, H. V., Lee, S., Kim, H. Y., Kim, W., Kim, T. S., Kim, D. J., & Kim, Y. S. (2014) · Scientific Reports · doi:10.1038/srep06777 · Cited by 37 · see citing works

A Nutritional Approach to Ameliorate Altered Phospholipid Metabolism in Alzheimer's Disease

Hartmann, T., van Wijk, N., Wurtman, R. J., Rikkert, M. G. M. O., Sijben, J., Soininen, H. S., Vellas, B. J., & Scheltens, P. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141137 · Cited by 35 · see citing works

The Influence of Sample Collection Methodology and Sample Preprocessing on The Blood Metabolic Profile

Jørgenrud, B., Jäntti, S. E., Mattila, I. M., Pöhö, P., Rnningen, K. S., Yki‐Järvinen, H., Orešič, M., & Hyötyläinen, T. (2015) · Bioanalysis · doi:10.4155/bio.15.16 · Cited by 35 · see citing works

Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus

Góth, L., Nagy, T., Kósa, Z., Fejes, Z., Bhattoa, H. P., Paragh, G., & Káplár, M. (2012) · Free Radical Research · doi:10.3109/10715762.2012.702899 · Cited by 34 · see citing works

The efficacy of supplementation with the novel medical food, Souvenaid, in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials

Onakpoya, I., & Heneghan, C. J. (2015) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1110899 · Cited by 32 · see citing works

Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles

Chan, M. K., Cooper, J. D., & Bahn, S. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.09.010 · Cited by 26 · see citing works

Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study

Agarwala, A., Virani, S. S., Couper, D. J., Chambless, L. E., Boerwinkle, E., Astor, B. C., Hoogeveen, R. C., Coresh, J., Sharrett, A. R., Folsom, A. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.028 · Cited by 21 · see citing works

A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development

Zhao, L., Jin, W., Rader, D. J., Packard, C. J., & Feuerstein, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.014 · Cited by 17 · see citing works

Biomarkers to Improve the benefit/risk Balance for Approved Therapeutics: a US FDA Perspective on Personalized Medicine

Sapsford, K. E., Težak, Ž., Kondratovich, M., Pacanowski, M. A., Zineh, I., & Mansfield, E. A. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.62 · Cited by 16 · see citing works

Pharmacogenomic Biomarker Information in FDA ‐approved Paediatric Drug Labels

Kim, T., Han, N., Sohn, M., Oh, J. M., Lee, E., Ji, E., & Kim, I. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12341 · Cited by 10 · see citing works

Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence

Foster, N. L., Hackett, J., White, G., Chenevert, S., Svarvar, P., Bain, L. J., & Carrillo, M. C. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.003 · Cited by 9 · see citing works

The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study

Cseprekál, O., Egresits, J., Tabák, Á. G., Nemcsik, J., Járai, Z., Babos, L., Fodor, E., Farkas, K., Godina, G., Kárpáthi, K. I., et al. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.96 · Cited by 8 · see citing works

Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes

Tehrani, D. M., & Wong, N. D. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0789-7 · Cited by 7 · see citing works

Differential Changes in Regional Brain Ganglioside and Neutral Glycosphingolipid Contents in Alzheimer’s Disease

Kin, N. M. K. N. Y., Pan, L. H., Louvaris, J. H., Robitaille, Y., & Nair, N. P. V. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1857-0_8 · Cited by 4 · see citing works

RE: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval

Freidlin, B., & Korn, E. L. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv430 · Cited by 3 · see citing works

FDA and CLIA Oversight of Advanced Diagnostics and Biomarker Tests

Terry, S. F. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.1510 · Cited by 2 · see citing works

[Companion diagnostics and reimbursement system].

Tazawa, Y. (2013) · PubMed · Cited by 1 · see citing works

Integrated community-based diagnostics services: a critical success factor in value-based reimbursement.

Laughman, K. (2014) · PubMed · Cited by 1 · see citing works

Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.

Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138 · see citing works

Alzheimer's Disease: Treatment Strategies and Their Limitations.

Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 592 · see citing works

Brain age and other bodily ‘ages’: implications for neuropsychiatry

Cole, J. H., Marioni, R. E., Harris, S. E., & Deary, I. J. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0098-1 · Cited by 436 · see citing works

Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies

Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353 · see citing works

Brain lipidomics: From functional landscape to clinical significance

Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324 · see citing works

Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease

Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 306 · see citing works

Cell-Type- and Brain-Region-Resolved Mouse Brain Lipidome

Fitzner, D., Bader, J. M., Penkert, H., Bergner, C. G., Su, M., Weil, M., Surma, M. A., Mann, M., Klose, C. D., & Simons, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108132 · Cited by 280 · see citing works

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease

Whelan, C. D., Mattsson, N., Nagle, M. W., Vijayaraghavan, S., Hyde, C., Janelidze, S., Stomrud, E., Lee, J., Fitz, L., Samad, T. A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0795-2 · Cited by 262 · see citing works

Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease

Su, H., Rustam, Y. H., Masters, C. L., Makalic, E., McLean, C., Hill, A. F., Barnham, K. J., Reid, G. E., & Vella, L. J. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12089 · Cited by 187 · see citing works

Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically

Ma, J., Hong, Y., Zheng, N., Xie, G., Lyu, Y., Gu, Y., Xi, C., Chen, L., Wu, G., Li, Y., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1763770 · Cited by 171 · see citing works

Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers

Mesa-Herrera, F., Taoro‐González, L., Valdés‐Baizabal, C., Díaz, M. L., & Marín, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153810 · Cited by 182 · see citing works

High fat diet-induced obesity leads to depressive and anxiety-like behaviors in mice via AMPK/mTOR-mediated autophagy

Li, Y., Cheng, Y., Zhou, Y., Du, H., Zhang, C., Zhao, Z., Chen, Y., Zhou, Z., Mei, J., Wu, W., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113949 · Cited by 150 · see citing works

Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease

McCartney, D. L., Stevenson, A. J., Walker, R. M., Gibson, J., Morris, S. W., Campbell, A., Murray, A. D., Whalley, H. C., Porteous, D. J., McIntosh, A. M., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.05.006 · Cited by 134 · see citing works

Cerebral consequences of environmental noise exposure

Hahad, O., Jiménez, M. T. B., Kuntić, M., Frenis, K., Steven, S., Daiber, A., & Münzel, T. F. (2022) · Environment International · doi:10.1016/j.envint.2022.107306 · Cited by 137 · see citing works

Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism

Akyol, S., Ugur, Z., Yılmaz, A., Ustun, I., Gorti, S. K. K., Oh, K., McGuinness, B., Passmore, P., Kehoe, P. G., Maddens, M. E., et al. (2021) · Cells · doi:10.3390/cells10102591 · Cited by 132 · see citing works

Mass spectrometry‐based lipidomics in food science and nutritional health: A comprehensive review

Sun, T., Wang, X., Cong, P., Xu, J., & Xue, C. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12603 · Cited by 127 · see citing works

Genetic architecture of Alzheimer's disease

Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126 · see citing works

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

Cano, A., Turowski, P., Ettcheto, M., Duskey, J. T., Tosi, G., Sánchez-López, E., García, M. L., Camins, A., Souto, E. B., Ruiz, A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00864-x · Cited by 122 · see citing works

An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease

Clark, C., Dayon, L., Masoodi, M., Bowman, G. L., & Popp, J. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00814-7 · Cited by 116 · see citing works

Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110 · see citing works

Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease

Prakash, P., Manchanda, P., Paouri, E., Bisht, K., Sharma, K., Rajpoot, J., Wendt, V., Hossain, A., Wijewardhane, P. R., Randolph, C. E., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.029 · Cited by 104 · see citing works

Lipids as biomarkers of brain disorders

Hussain, G., Anwar, H., Rasul, A., Imran, A., Qasim, M., Zafar, S., Imran, M., Kamran, S., Aziz, N., Razzaq, A., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1529653 · Cited by 105 · see citing works

Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis

Weidling, I. W., & Swerdlow, R. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113321 · Cited by 100 · see citing works

Exploring the Lipidome: Current Lipid Extraction Techniques for Mass Spectrometry Analysis

Aldana, J., Romero-Otero, A., & Cala, M. P. (2020) · Metabolites · doi:10.3390/metabo10060231 · Cited by 100 · see citing works

Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease

López‐Ortiz, S., Pinto-Fraga, J., Valenzuela, P. L., Martín-Hernández, J., Seisdedos, M. M., Garcı́a, Ó., Toschi, N., Giuliano, F. D., Garaci, F. G., Mercuri, N. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062897 · Cited by 101 · see citing works

Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia

Kim, O. Y., & Song, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122356 · Cited by 96 · see citing works

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease

Park, S. A., Han, S. M., & Kim, C. E. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0418-9 · Cited by 91 · see citing works

Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review

Agarwal, M., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.12008 · Cited by 85 · see citing works

Age and sex are associated with the plasma lipidome: findings from the GOLDN study

Slade, E., Irvin, M. R., Xie, K., Arnett, D. K., Claas, S. A., Kind, T., Fardo, D. W., & Graf, G. A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01456-2 · Cited by 83 · see citing works

Oxidative Damage and Antioxidant Response in Frontal Cortex of Demented and Nondemented Individuals with Alzheimer’s Neuropathology

Fracassi, A., Marcatti, M., Zolochevska, O., Tabor, N., Woltjer, R., Moreno, S., & Taglialatela, G. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.0295-20.2020 · Cited by 81 · see citing works

Deep learning-based identification of genetic variants: application to Alzheimer’s disease classification

Jo, T., Nho, K., Bice, P., Saykin, A. J., & Initiative, F. T. A. D. N. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac022 · Cited by 80 · see citing works

Comparison of Single Phase and Biphasic Extraction Protocols for Lipidomic Studies Using Human Plasma

Wong, M. W. K., Braidy, N., Pickford, R., Sachdev, P. S., & Poljak, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00879 · Cited by 75 · see citing works

Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases

Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 81 · see citing works

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology

Barupal, D. K., Baillie, R., Fan, S., Saykin, A. J., Meikle, P. J., Arnold, M., Nho, K. T., Fiehn, O., Kaddurah-Daouk, R. F., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.002 · Cited by 74 · see citing works

Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives

Lista, S., González‐Domínguez, R., López‐Ortiz, S., González‐Domínguez, Á., Menéndez, H., Martín-Hernández, J., Lucía, A., Emanuele, E., Centonze, D., Imbimbo, B. P., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101987 · Cited by 75 · see citing works

Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging

Dorninger, F., Moser, A. B., Kou, J., Wiesinger, C., Forss-Petter, S., Gleiss, A., Hinterberger, M., Jungwirth, S., Fischer, P., & Berger, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171036 · Cited by 70 · see citing works

Brain lipidomics as a rising field in neurodegenerative contexts: Perspectives with Machine Learning approaches.

Castellanos, D. B., Martín-Jiménez, C., Rojas-Rodríguez, F., Barreto, G., & Santos, J. G. (2021) · Frontiers in neuroendocrinology (Print) · doi:10.1016/j.yfrne.2021.100899 · Cited by 58 · see citing works

Curcumin Alleviates DSS‐Induced Anxiety‐Like Behaviors via the Microbial‐Brain‐Gut Axis

Zhang, F., Zhou, Y., Chen, H., Jiang, H., Zhou, F., Lü, B., & Xu, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6244757 · Cited by 69 · see citing works

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort

Barupal, D. K., Fan, S., Wancewicz, B., Cajka, T., Sa, M., Showalter, M. R., Baillie, R., Tenenbaum, J. D., Louie, G., Initiative, A. D. N., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.263 · Cited by 65 · see citing works

Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study

Fernández‐Irigoyen, J., Cartas‐Cejudo, P., Iruarrizaga‐Lejarreta, M., & Santamaría, E. (2021) · Biomedicines · doi:10.3390/biomedicines9050491 · Cited by 66 · see citing works

New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease

Cao, Y., Zhao, L., Chen, Z., & Li, S. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 58 · see citing works

Platelet biomarkers for a descending cognitive function: A proteomic approach

Yu, H., Liu, Y., He, B., He, T., Chen, C., He, J., Yang, X., & Wang, J. (2021) · Aging Cell · doi:10.1111/acel.13358 · Cited by 56 · see citing works

Recent progresses of derivatization approaches in the targeted lipidomics analysis by mass spectrometry

Zhao, X., Zhu, S., & Liu, H. (2020) · Journal of Separation Science · doi:10.1002/jssc.201901346 · Cited by 56 · see citing works

Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration

Labarre, A., Guitard, E., Tossing, G., Forest, A., Bareke, E., Labrecque, M., Tétreault, M., Ruiz, M., & Parker, J. A. (2022) · Communications Biology · doi:10.1038/s42003-022-04295-8 · Cited by 53 · see citing works

Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties

Siddiqui, A., Shah, Z., Jahan, R. N., Othman, I., & Kumari, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112250 · Cited by 54 · see citing works

Plasma lipidome variation during the second half of the human lifespan is associated with age and sex but minimally with BMI

Wong, M. W. K., Braidy, N., Pickford, R., Vafaee, F., Crawford, J. D., Muenchhoff, J., Schofield, P. W., Attia, J., Brodaty, H., Sachdev, P. S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214141 · Cited by 51 · see citing works

Interaction of Aβ42 with Membranes Triggers the Self-Assembly into Oligomers

Banerjee, S., Hashemi, M., Zagorski, K., & Lyubchenko, Y. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031129 · Cited by 50 · see citing works

Effects of Acupuncture on Alzheimer’s Disease: Evidence from Neuroimaging Studies

Yu, C.-C., Ma, C., Wang, H., Kong, L.-H., Zhao, Y., Shen, F., & Wu, M. (2018) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-018-2993-3 · Cited by 44 · see citing works

Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer’s disease and vascular dementia

Chua, X. Y., Torta, F. T., Chong, J. R., Venketasubramanian, N., Hilal, S., Wenk, M. R., Chen, C., Arumugam, T. V., Herr, D. R., & Lai, M. K. P. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01359-7 · Cited by 43 · see citing works

Determination of lipid profiles of Dezhou donkey meat using an LC‐MS‐based lipidomics method

Li, M., Zhu, M., Chai, W., Wang, Y., Fan, D., Lv, M., Jiang, X., Liu, Y., Wei, Q., & Wang, C. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15917 · Cited by 39 · see citing works

Amyloid β Induces Lipid Droplet‐Mediated Microglial Dysfunction in Alzheimer’s Disease

­Prakash, P., Manchanda, P., Paouri, E., Bisht, K., Sharma, K. P., Rajpoot, J., Wendt, V., Hossain, A., Wijewardhane, P. R., Randolph, C. E., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.075938 · Cited by 38 · see citing works

Unraveling metabolic alterations in transgenic mouse model of Alzheimer's disease using MALDI MS imaging with 4-aminocinnoline-3-carboxamide matrix

Chen, Y., Hu, D., Zhao, L., Tang, W., & Li, B. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339337 · Cited by 35 · see citing works

High‐Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer’s Disease

Bosoi, C. R., Vandal, M., Tournissac, M., Leclerc, M., Fanet, H., Mitchell, P. L., Verreault, M., Trottier, J., Virgili, J., Tremblay, C., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1609 · Cited by 32 · see citing works

An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington’s disease caudate nucleus

Hunter, M., Demarais, N. J., Faull, R. L. M., Grey, A. C., & Curtis, M. A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15325 · Cited by 32 · see citing works

Dyslipidemia induced large-scale network connectivity abnormality facilitates cognitive decline in the Alzheimer’s disease

Wang, Q., Zang, F., He, C., Zhang, Z., Xie, C., & Initiative, A. D. N. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03786-w · Cited by 32 · see citing works

Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia

Liu, Y., Chan, D. K. Y., Thalamuthu, A., Wen, W. X., Jiang, J., Paradise, M., Lee, T., Crawford, J. D., Wong, M. W. K., Xu, Y. H., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.001 · Cited by 31 · see citing works

A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia

Ma, Y., Shen, X., Xu, W., Huang, Y., Li, H., Tan, L., Tan, C., Dong, Q., Tan, L., Yu, J., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12041 · Cited by 31 · see citing works

Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways

Siddiqui, A., Akhtar, S., Shah, Z., Othman, I., & Kumari, Y. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200924122732 · Cited by 30 · see citing works

Mass spectrometry is a multifaceted weapon to be used in the battle against Alzheimer's disease: Amyloid beta peptides and beyond

Grasso, G. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21566 · Cited by 30 · see citing works

Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma

Khan, M. J., Codreanu, S. G., Goyal, S., Wages, P. A., Gorti, S. K. K., Pearson, M. J., Uribe, I. R., Sherrod, S. D., MCLEAN, J. A. J., Porter, N. A., et al. (2020) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8911 · Cited by 28 · see citing works

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease

Dulewicz, M., Kulczyńska‐Przybik, A., Słowik, A., Borawska, R., & Mroczko, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143009 · Cited by 28 · see citing works

Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood

Wang, Y., Sun, Y., Luo, Y., Peng, D., Li, X., Yang, B., Wang, Q., & Kuang, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.700587 · Cited by 28 · see citing works

HILIC/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: Dysregulation in pancreatic cancer

Peterka, O., Maccelli, A., Jirásko, R., Vaňková, Z., Idkowiak, J., Hrstka, R., Wolrab, D., & Holčapek, M. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.342144 · Cited by 27 · see citing works

The early diagnosis of Alzheimer's disease: Blood‐based panel biomarker discovery by proteomics and metabolomics

Dong, Y., Song, X., Wang, X., Wang, S., & He, Z. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70060 · Cited by 32 · see citing works

The Role of Amyloid β‐Biomembrane Interactions in the Pathogenesis of Alzheimer's Disease: Insights from Liposomes as Membrane Models

Andrade, S., Loureiro, J. A., & Pereira, M. D. C. (2021) · ChemPhysChem · doi:10.1002/cphc.202100124 · Cited by 26 · see citing works

Association of Circulating Apolipoprotein AI Levels in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis

Tong, J., Gong, S., Zhang, Y.-S., Dong, J.-R., Zhong, X., Wei, M., & Liu, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.899175 · Cited by 28 · see citing works

Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression

Afrin, M. R., Upadhyaya, P. G., Hashim, A., Bhattacharya, K., Chanu, N. R., Das, D., Khanal, P., & Deka, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102736 · Cited by 24 · see citing works

Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer’s Disease as Identified by Targeted Metabolomics

Marksteiner, J., Oberacher, H., & Humpel, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181278 · Cited by 24 · see citing works

Spatially resolved mass spectrometry analysis of amyloid plaque‐associated lipids

Blank, M., & Hopf, C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15216 · Cited by 24 · see citing works

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease

Jääskeläinen, O., Hall, A., Tiainen, M., van Gils, M., Lötjönen, J. M. P., Kangas, A. J., Helisalmi, S., Pikkarainen, M., Hallikainen, M., Koivisto, A. M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191226 · Cited by 23 · see citing works

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome

Mapstone, M. E., Gross, T. J., Macciardi, F. M., Cheema, A. K., Petersen, M. E., Head, E., Handen, B. L., Klunk, W. E., Christian, B. T., Silverman, W. P., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12028 · Cited by 23 · see citing works

Plasmalogens improve swimming performance by modulating the expression of genes involved in amino acid and lipid metabolism, oxidative stress, and ferroptosis in an Alzheimer's disease zebrafish model

Feng, J., Song, G., Wu, Y., Chen, X., Pang, J., Xu, Y., Shen, Q., Guo, S., & Zhang, M. (2021) · Food & Function · doi:10.1039/d1fo01471d · Cited by 22 · see citing works

FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer’s Disease

Depciuch, J., Zawlik, I., Skrzypa, M., Pająk, J., Potocka, N., Łach, K., Bartosik-Psujek, H., Koziorowska, A. M., Kaznowska, E. B., & Cebulski, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181008 · Cited by 22 · see citing works

Associations among drinking water quality, dyslipidemia, and cognitive function for older adults in China: evidence from CHARLS

Pan, X., Luo, Y., Zhao, D., & Zhang, L. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03375-y · Cited by 22 · see citing works

Aβ modulates actin cytoskeleton via SHIP2-mediated phosphoinositide metabolism

Lee, H. N., Sim, K. M., Kim, H., Ju, J.-M., Pae, A. N., Park, J., Ryu, H., & Seong, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51914-2 · Cited by 20 · see citing works

Preserving Brain LPC‐DHA by Plasma Supplementation Attenuates Brain Injury after Cardiac Arrest

Nishikimi, M., Shoaib, M., Choudhary, R. C., Aoki, T., Miyara, S. J., Yagi, T., Hayashida, K., Takegawa, R., Yin, T., Becker, L. B., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26296 · Cited by 20 · see citing works

Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism

Jiang, J., Shi, H., Jiang, S., Wang, A., Zou, X., Wang, Y., Li, W., Zhang, Y., Sun, M., Ren, Q., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2276-6 · Cited by 20 · see citing works

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology

Dong, R., Lu, Q., Kang, H., Suridjan, I., Kollmorgen, G., Wild, N., Deming, Y. K., Hulle, C. A. V., Anderson, R. M., Zetterberg, H., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1214932 · Cited by 20 · see citing works

Mass spectrometry imaging of free-floating brain sections detects pathological lipid distribution in a mouse model of Alzheimer's-like pathology

Strnad, Š., Pražienková, V., Holubová, M., Sýkora, D., Cvačka, J., Maletı́nská, L., Železná, B., Kuneš, J., & Vrkoslav, V. (2020) · The Analyst · doi:10.1039/d0an00592d · Cited by 19 · see citing works

The Impact of the hAPP695 SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways

Khorani, M., Bobe, G., Matthews, D. G., Magaña, A. A., Caruso, M. A., Gray, N. E., Quinn, J. F., Stevens, J. F., Soumyanath, A., & Maier, C. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215084 · Cited by 18 · see citing works

Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer’s Disease

Sakr, F., Initiative, A. D. N., Dyrba, M., Bräuer, A., & Teipel, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201504 · Cited by 19 · see citing works

Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer’s disease

Liu, L., Yue, H.-Y., Zou, J., Tang, M., Zou, F.-M., Li, Z.-L., Jia, Q., Li, Y., Kang, J., & Zuo, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1076960 · Cited by 19 · see citing works

Change in lipids before onset of dementia, coronary heart disease, and mortality: A 28‐year follow‐up Whitehall II prospective cohort study

Hassen, C. B., Machado‐Fragua, M. D., Landré, B., Fayossé, A., Dumurgier, J., Mika Kivimaki, B., Sabia, S., & Singh‐Manoux, A. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13140 · Cited by 19 · see citing works

Genetic and environmental determinants of variation in the plasma lipidome of older Australian twins

Wong, M. W. K., Thalamuthu, A., Braidy, N., Mather, K. A., Liu, Y., Ciobanu, L. G., Baune, B. T., Armstrong, N. J., Kwok, J. B., Schofield, P. R., et al. (2020) · eLife · doi:10.7554/elife.58954 · Cited by 18 · see citing works

An immune response characterizes early Alzheimer’s disease pathology and subjective cognitive impairment in hydrocephalus biopsies

Huang, W., Bartosch, A. M. W., Xiao, H., Maji, S., Youth, E. H. H., Flowers, X. E., Leskinen, S., Tomljanovic, Z., Iodice, G. M., Boyett, D. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25902-y · Cited by 17 · see citing works

An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease

Chan, H., Ke, L., Lu, H.-T., Weng, S., Chan, H., Law, S., Lin, I., Chang, C., Lu, Y., Chen, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8120542 · Cited by 18 · see citing works

Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine

Long, J., Zhang, J., Zeng, X., Wang, M., & Wang, N. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70101 · Cited by 17 · see citing works

Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.

Sakr, F. A., Dyrba, M., Bräuer, A. U., Teipel, S. J., & Initiative, A. D. N. (2022) · DZNE Pub · Cited by 17 · see citing works

Mapping the lipidome in mitochondria‐associated membranes ( MAMs ) in an in vitro model of Alzheimer's disease

Fernandes, T., Melo, T., Conde, T., Neves, B., Domingues, P. M., Resende, R., Pereira, C., Moreira, P. I., & Domingues, M. R. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16072 · Cited by 17 · see citing works

Metabolomic Study of Urine from Workers Exposed to Low Concentrations of Benzene by UHPLC-ESI-QToF-MS Reveals Potential Biomarkers Associated with Oxidative Stress and Genotoxicity

Mendes, M. P. R., de Paiva, M. J. N., Costa‐Amaral, I. C., de Carvalho, L. V. B., Figueiredo, V. O., Gonçalves, E. S., Larentis, A. L., & André, L. C. (2022) · Metabolites · doi:10.3390/metabo12100978 · Cited by 16 · see citing works

Understanding Neurodegenerative Disorders by MS-based Lipidomics

Calvano, C. D., Palmisano, F., & Cataldi, T. R. I. (2018) · Bioanalysis · doi:10.4155/bio-2018-0023 · Cited by 16 · see citing works

Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence

Granzotto, A., Bomba, M., Castelli, V., Navarra, R., Massetti, N., D’Aurora, M., ONOFRJ, M. C., Cicalini, I., Boccio, P. D., Gatta, V., et al. (2019) · Aging · doi:10.18632/aging.102191 · Cited by 16 · see citing works

APOE Genotype Differentially Modulates Plasma Lipids in Healthy Older Individuals, with Relevance to Brain Health

Wong, M. W. K., Braidy, N., Crawford, J., Pickford, R., Song, F., Mather, K. A., Attia, J., Brodaty, H., Sachdev, P. S., & Poljak, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190524 · Cited by 16 · see citing works

Lower serum triglyceride levels linked to more severe motor performance in Parkinson’s disease

Zhang, M., Chen, H., Liu, G., Wang, X., Wang, Z., Feng, T., & Zhang, Y. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06113-9 · Cited by 15 · see citing works

Integrated untargeted and targeted metabolomics to reveal therapeutic effect and mechanism of Alpiniae oxyphyllae fructus on Alzheimer’s disease in APP/PS1 mice

Zhou, S., Liu, L., Zhang, Y., Zhang, Z., Li, H., Fan, F., He, J., Kang, J., & Zuo, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1104954 · Cited by 15 · see citing works

Aza-Prilezhaev Aziridination-Enabled Multidimensional Analysis of Isomeric Lipids via High-Resolution U-Shaped Mobility Analyzer–Mass Spectrometry

Li, Y., Wang, Y., Guo, K., Tseng, K.-F., Zhang, X., & Sun, W. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00481 · Cited by 15 · see citing works

Moxibustion for cognitive impairment: A systematic review and meta-analysis of animal studies

Aum, S., Choe, S., Cai, M., Jerng, U. M., & Lee, J. (2020) · Integrative Medicine Research · doi:10.1016/j.imr.2020.100680 · Cited by 15 · see citing works

Targeted Lipidomics To Measure Phospholipids and Sphingomyelins in Plasma: A Pilot Study To Understand the Impact of Race/Ethnicity in Alzheimer’s Disease

Khan, M. J., Chung, N. A., Hansen, S., Dumitrescu, L. C., Hohman, T. J., Kamboh, M. I., López, O. L., & Robinson, R. A. S. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03821 · Cited by 15 · see citing works

The Potential of ‘Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer’s Disease in African Americans

Stepler, K. E., & Robinson, R. A. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_1 · Cited by 15 · see citing works

Genome Sequencing Variations in the Octodon degus, an Unconventional Natural Model of Aging and Alzheimer's Disease

Hurley, M. J., Urra, C., Garduño, B. M., Bruno, A., Kimbell, A., Wilkinson, B., Marino‐Buslje, C., Ezquer, M., Ezquer, F. E., Fernández‐Aburto, P., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.894994 · Cited by 14 · see citing works

Lipidomics of Alzheimer’s Disease

Touboul, D., & Gaudin, M. (2014) · Bioanalysis · doi:10.4155/bio.13.346 · Cited by 52 · see citing works

Lipids and Alzheimer’s Disease

Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485 · see citing works

Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease

Byeon, S. K., Madugundu, A. K., Jain, A., Bhat, F. A., Jung, J. H., Renuse, S., Darrow, J. A., Bakker, A., Albert, M., Moghekar, A., et al. (2021) · Molecular Omics · doi:10.1039/d0mo00186d · Cited by 48 · see citing works

Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications

He, S., Xu, Z., & Han, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00803-6 · Cited by 62 · see citing works

The application of lipidomics to biomarker research and pathomechanisms in Alzheimer's disease

Wong, M. W. K., Braidy, N., Poljak, A., & Sachdev, P. S. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000303 · Cited by 49 · see citing works